Last updated: March 13, 2025
Sponsor: Chang Gung Memorial Hospital
Overall Status: Completed
Phase
2
Condition
Rosacea
Treatment
dian dao san
Clinical Study ID
NCT05045469
202101000A3
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Willing to sign inform consent
Aged above 20 years old with rosacea
No treatment for rosacea within 2 weeks
Exclusion
Exclusion Criteria:
With malignant lesion in the rosacea lesion
Rosacea lesion with high risk of infection
Allergy to Chinese herbal medicine patch or ointment
Pregnancy
Study Design
Total Participants: 24
Treatment Group(s): 1
Primary Treatment: dian dao san
Phase: 2
Study Start date:
August 04, 2021
Estimated Completion Date:
August 04, 2024
Study Description
Connect with a study center
Keelung Chang Gung Memorial Hospital
Keelung,
TaiwanSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.